Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 13, 2020
Brief Report: Sex Differences in Outcomes for Individuals Presenting for Third-Line Antiretroviral Therapy
Catherine Godfrey, Michael D Hughes, Justin Ritz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2020
Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation
Trevor A Crowell, Justin Ritz, Robert W Coombs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19
Nikolaus Jilg, Mark J Giganti, Kara W Chew, et al.
RNA (New York, N.Y.)
|
May 26, 2011
Sharing and archiving nucleic acid structure mapping data
Philippe Rocca-Serra, Stanislav Bellaousov, Amanda Birmingham, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 15, 2019
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings
Carole L Wallis, Michael D Hughes, Justin Ritz, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Immune Status and SARS-CoV-2 Viral Dynamics
Yijia Li, Carlee Moser, Evgenia Aga, et al.
The Journal of Infectious Diseases
|
April 22, 2017
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
Cynthia L Gay, Ronald J Bosch, Justin Ritz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2022
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019
Yijia Li, Linda J Harrison, Kara W Chew, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 13, 2020
Brief Report: Sex Differences in Outcomes for Individuals Presenting for Third-Line Antiretroviral Therapy
Catherine Godfrey, Michael D Hughes, Justin Ritz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2020
Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation
Trevor A Crowell, Justin Ritz, Robert W Coombs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19
Nikolaus Jilg, Mark J Giganti, Kara W Chew, et al.
RNA (New York, N.Y.)
|
May 26, 2011
Sharing and archiving nucleic acid structure mapping data
Philippe Rocca-Serra, Stanislav Bellaousov, Amanda Birmingham, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 15, 2019
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings
Carole L Wallis, Michael D Hughes, Justin Ritz, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Immune Status and SARS-CoV-2 Viral Dynamics
Yijia Li, Carlee Moser, Evgenia Aga, et al.
The Journal of Infectious Diseases
|
April 22, 2017
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
Cynthia L Gay, Ronald J Bosch, Justin Ritz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2022
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019
Yijia Li, Linda J Harrison, Kara W Chew, et al.
Page
of 6